Exchange: NYSE·Updated 12:00 PM EDT

LLY News

News
all
press releases
Novo Nordisk Taps Anthropic’s Claude Science To Speed Up Drug Discovery — Here’s Everything Investors Need To Know
Novo will use Anthropic’s Claude Science in R&D to tackle scientific and drug discovery challenges, aiming to develop new medicines faster.
Stocktwits
More News
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks
NVO To Present Fresh Data From Blockbuster Wegovy Pill At European Conference As Rival Eli Lilly Readies Its Own Obesity Updates
Novo said it will present 44 abstracts at the European Association for the Study of Diabetes symposium later this month.
Stocktwits
Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything
Key PointsEli Lilly's breakthroughs in its core therapeutic area are driving excellent financial results...
Nasdaq News: Markets
Can Redwire's Microgravity Platform Expand Commercial Opportunities?
RDW turns microgravity into a commercial platform, spanning pharmaceutical research, biotechnology and advanced manufacturing.
Zacks
Eli Lilly To Present Fresh Data On Foundayo, Retatrutide In Europe – Here’s Why Berenberg Sees A 21% Potential Upside In LLY Stock
Berenberg sees potential upside to Lilly’s full-year 2026 revenue forecast, which ranges from $85 billion to $87 billion.
Stocktwits
Eli Lilly Stock Gains as Retatrutide and Foundayo Data Highlight Pipeline Strength
Shares of Eli Lilly and Company are trading higher Tuesday following positive previews of its late-stage obesity and diabetes pipeline.read more...
Benzinga
Futures Drop As Yields, Oil Prices Keep Rising
Futures Drop As Yields, Oil Prices Keep Rising Futures are lower - but well off session lows thanks to some well-time oil sell orders just before US traders walked in to work - as bond yields continue to make new highs, with both Nasdaq and Russell lagging the S&P which feels like...
Zero Hedge
Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health
Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic healthPR...
PR Newswire
Can Viking Therapeutics Beat Big Pharma With Monthly Weight-Loss Shots? Here’s The Risk CEO Says Could Derail It
CEO Brian Lian said monthly VK2735 must preserve weight loss without restarting nausea, vomiting and other gastrointestinal effects.
Stocktwits

Advertisement|Remove ads.